AVCNF - Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3 Introduces New Platform | Benzinga
Avicanna Inc. (OTCQX: AVCNF) a biopharmaceutical company specializing in proprietary cannabinoid-based products, announced Q3 2023 results late Tuesday, highlighted by the successful acquisition of Medical Cannabis by Shoppers assets, paving the way for the launch of the innovative MyMedi.ca platform.
Leadership Insight
Aras Azadian, CEO of Avicanna Inc., emphasized the company's strategic vision. "We had the boldness to take on the challenge of acquiring the Medical Cannabis by Shoppers business and executed on integrating it into the newly developed MyMedi.ca" he